Last update:

HIV & AIDS news

HIV & AIDS

Social programs could cut HIV spread by 29%, study finds

Researchers at the University of Massachusetts Amherst have quantified the impacts of a constellation of social factors on the spread of HIV. Their study, published in Health Care Management Science, found that a hypothetical ...

HIV & AIDS

Global study: HIV patients face underestimated heart disease risks

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV (PWH). To address this, CVD prevention plans rely on prediction models like ...

HIV & AIDS

HIV vaccine candidate activates crucial immune function

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies.

HIV & AIDS

New mechanism found in statin therapy's heart benefits for HIV

Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize plaques and prevent their rupture ...

Medical research

HIV: There's hope for a cure—where we stand now

With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ambitious goal: finding a cure for HIV/Aids.

HIV & AIDS

Considerable scale-up needed to achieve 2025 goals for HIV PrEP

Considerable scale-up is needed to achieve the 2025 goals for HIV preexposure prophylaxis (PrEP), according to research published in the Nov. 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality ...

HIV & AIDS

Why is a cure for HIV so elusive?

Schulich School of Medicine & Dentistry researchers are on the cutting-edge of the study of HIV, working toward treatments and a better understanding of how the virus works.

HIV & AIDS

Fewest new HIV cases since late 1980s: UNAIDS report

Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations said Tuesday, warning that this decline was still far too slow.

HIV & AIDS

Study links historical redlining to delays in HIV treatment

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment within affected neighborhoods.

HIV & AIDS

Survey finds continued declines in HIV clinician workforce

The supply of health care professionals available to provide HIV care continues to decline, even as the need for HIV care and prevention is expected to increase, reports a survey study in the November/December issue of the ...

HIV & AIDS

New gene discovery aids HIV vaccine progress

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans.

HIV & AIDS

Success of long-lasting HIV drug hinges on pricing

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has proven highly effective in human trials, say global health specialists.

HIV & AIDS

Sweden meets U.N. targets for combating HIV epidemic: Study

Sweden has reached the UNAIDS and WHO targets for the HIV epidemic, according to a study in Eurosurveillance by researchers at Karolinska Institutet and others. According to the researchers, Sweden is the first country in ...

HIV & AIDS

Study finds telehealth effective for HIV patients

A Rutgers Health study suggests telehealth could be a viable long-term option for people living with HIV, potentially saving them time, effort and expense related to in-person medical visits.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.